{"id":"W4414710160","doi":"10.1016/j.esmoop.2025.105542","title":"Pembrolizumab with trastuzumab and chemotherapy for HER2-positive advanced gastric cancer: health-related quality-of-life analysis from the randomized KEYNOTE-811 trial","year":2025,"lang":"en","type":"article","venue":"ESMO Open","topic":"Gastric Cancer Management and Outcomes","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"ca_institutions":"Trinity College","funders":"National Cancer Institute; Astellas Pharma; Society for Anthropological Sciences; Merck Sharp and Dohme; Merck; MSD","keywords":"Pembrolizumab; Trastuzumab; Chemotherapy; Clinical trial; Randomized controlled trial; Cancer","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001120538,0.0002339944,0.001966713,0.0001895728,0.000171994,0.00006545088,0.0002943575,0.00006463371,0.0001987985],"category_scores_gemma":[0.0002396855,0.0001433712,0.0003249268,0.00110071,0.0001607481,0.00009874933,0.00008717102,0.0001590131,5.772113e-7],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0001584327,"about_ca_system_score_gemma":0.0005126346,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.03515515,"about_ca_topic_score_gemma":0.003683013,"domain_scores_codex":[0.9978853,0.0003262309,0.0008262895,0.0004308915,0.0002594843,0.0002717709],"domain_scores_gemma":[0.9975277,0.001325344,0.0005423775,0.0003868349,0.0001181994,0.00009957339],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.9392354,0.000177533,0.01935302,0.00007734733,0.008707829,0.00000132064,0.001063503,0.000115143,0.000003793982,0.0007603398,0.002048781,0.02845602],"study_design_scores_gemma":[0.7998461,0.0006948123,0.1935838,0.0001665574,0.00266962,4.037614e-7,0.0006286787,0.0004548403,0.00003657867,0.00030467,0.001467043,0.0001469743],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9287146,0.002248668,0.01080623,0.04345875,0.0002824007,0.01253533,0.0001638013,0.00004768652,0.001742466],"genre_scores_gemma":[0.9894052,0.001033366,0.001708919,0.003957517,0.00007491242,0.0008320695,0.0002007786,0.00002385835,0.002763447],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.1742308,"threshold_uncertainty_score":0.9712698,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.02730956368770292,"score_gpt":0.3591426641774245,"score_spread":0.3318331004897216,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}